A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Subjects With Newly Diagnosed Glioblastoma
Condition: Glioblastoma Interventions: Drug: CC-90010; Drug: Temozolomide Sponsor: Celgene Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials